arrow
C

Christoph Licht

The Hospital for Sick Children
H指数:52
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IPNA clinical practice recommendations for the management of aHUS and secondary TMA in children

国际小儿肾脏病学会(IPNA)关于儿童补体介导血栓性微血管病(aHUS和继发性TMA)管理的临床实践建议

2026-09-230
OAAI
Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN: Phase 3 VALIANT Subgroup Analysis

pegcetacoplan治疗C3肾小球病或原发性免疫复合物膜增生性肾小球肾炎的青少年:III期VALIANT亚组分析

2026-05-011
PRE
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN

Pegcetacoplan在C3肾小球病和免疫复合物型MPGN中的试验

2025-12-044
PRE
Mental health among caregivers of children with nephrotic syndrome: a prospective cohort study

肾病综合征儿童照护者的心理健康状况:一项前瞻性队列研究

2025-11-260
PRE
Establishing core outcomes and minimal clinically important differences for childhood steroid sensitive nephrotic syndrome clinical trials: results from a Delphi consensus process

建立儿童糖皮质激素敏感型肾病综合征临床试验的核心结局指标和最小临床意义差异:Delphi共识过程的结果

2025-10-140
PRE
Steroid-sparing drugs in children and young adults with nephrotic syndrome: a target trial emulation

糖皮质激素减量药物在儿童和青年肾病患者中的使用:一项目标试验模拟研究

2025-10-010
PRE
Targeted treatment with pegcetacoplan for adolescents with C3G or primary (idiopathic) IC-MPGN in the VALIANT Phase 3 trial

VALIANT III期临床试验中,使用pegcetacoplan针对青少年C3G或原发性(特发性)IC-MPGN的靶向治疗

2025-10-010
OAAI
Challenging Clinical Practice Guideline Definitions in Childhood Nephrotic Syndrome

挑战儿童肾病综合征的临床实践指南定义

2025-10-011
PRE
Pegcetacoplan treatment appears to halt disease progression in C3G and primary (idiopathic) IC-MPGN patients: results from the phase 3 VALIANT study

Pegcetacoplan治疗似乎可阻止C3G和原发性(特发性)IC-MPGN患者的疾病进展:VALIANT III期研究的结果

2025-10-010
OAAI
Comparing outcomes with different dialysis modalities in children with kidney failure: home hemodialysis versus in-center hemodiafiltration or conventional hemodialysis

比较不同透析模式在儿童肾衰竭患者中的结局:居家血液透析与透析中心血液透析滤过或常规血液透析的比较

2025-08-120
PRE
Longitudinal medication adherence in children with nephrotic syndrome and association with disease outcomes

肾病综合征患儿的纵向用药依从性及其与疾病结局的关联

2025-07-010
PRE
Complement activation in a phase Ib study of fordadistrogene movaparvovec for Duchenne muscular dystrophy

福特达西罗金-莫瓦帕罗韦克(fordadistrogene movaparvovec)在杜氏肌营养不良症(Duchenne muscular dystrophy)的 Ib 期研究中的补体激活

2025-06-280
PRE
Comparative Efficacy of Nonsteroid Immunosuppressive Medications in Childhood Nephrotic Syndrome

非甾体免疫抑制药物在儿童肾病综合征中的比较疗效

2025-01-270
PRE